Thursday, January 31, 2019

Types of exercise | Massage | Flu diagnosis | Multiple sclerosis | Abnormal heartbeats

Discover four types of exercise, how massage may help back pain, lab tests for the flu, and more.
HIP Newsletter Banner (No Border)

Thursday, January 31, 2019

Types of Exercise

A mature woman at the gym lifting light weights.

Aim to do all four types of exercise—strength, endurance, flexibility, and balance. (From NIH's NIA)


Health Benefits of Massage

A rolled up towel on top of a massage table.

Results from studies on massage therapy are preliminary or conflicting. Find out what the science says. (From NIH's NCCIH)


How Is Flu Diagnosed?

A young girl with the flu blowing her nose.

Flu medicines work best when taken within 2 days of getting sick. Your doctor can use lab tests to know for sure whether you have flu. (From NIH's NIAID)


Managing Multiple Sclerosis

A pharmacist handing a woman her prescription.

Medicine can help people with multiple sclerosis delay having a future attack of symptoms. (From NIH News in Health)


AI Detects Abnormal Heartbeat

An EKG monitor showing a heart beat.

Researchers used heartbeat data from 53,000 people to train artificial intelligence and found that it could spot abnormal heartbeats faster than doctors. (From NIH Director's Blog)



This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612 GovDelivery logo

NIDCR Science News - January 2019

Having trouble viewing this email? View it as a Web page.

national institute of dental and craniofacial research
   

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Dental and Craniofacial Research · 9000 Rockville Pike · Bethesda, MD 20892 GovDelivery logo

Updates to the Candida Infections Section of the Pediatric Opportunistic Infections Guidelines

 

 

 

     
   
 
 

At-a-Glance

 
Issue No. 2 | January 31, 2019 View HTML version
 
 
News and Features

Updates to the Candida Infections Section of the Pediatric Opportunistic Infections Guidelines

The Candida Infections section of the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children has been updated.


There are no major changes to the guidance for the diagnosis and management of Candida infections in children and adolescents living with HIV. Minor updates to the main text of the section include new diagnostic methodologies and a restructured subsection on Pharmacokinetics and Dosing of Antifungals, including the newer agents posaconazole and isavuconazole. The section has been updated to reflect the new recommendation rating system and references were added.



AIDSinfo Updates Consumer Fact Sheets on HIV and Pregnancy

The updated AIDSinfo consumer fact sheets highlight strategies used before and after childbirth to prevent mother-to-child transmission of HIV. Each fact sheet includes a summary of key points and links to additional information and resources.


View the updated fact sheets:

Visit infoSIDA to view the fact sheets in Spanish.



February 7 is National Black HIV/AIDS Awareness Day

According to the Centers for Disease Control and Prevention (CDC), compared to other races/ethnicities in the United States, African Americans account for a higher proportion of those with new HIV diagnoses, those living with HIV, and those who have ever received an AIDS diagnosis. For example, CDC reports that in 2016, African Americans accounted for 44% of HIV diagnoses, despite making up only 12% of the U.S. population.


February 7 is National Black HIV/AIDS Awareness Day—an annual opportunity to promote HIV education, testing, community involvement, and treatment in black communities. To learn more, visit the AIDSinfo National Black HIV/AIDS Awareness Day webpage [en español].

 
 
     
 
Home | Guidelines | Understanding HIV/AIDS | Drugs | Clinical Trials | Research
Contact Us
 
 
     

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: AIDSinfo · P.O. Box 4780· Rockville, MD 20849-6303 GovDelivery logo

NINR News and Notes Digest, January 2019

Having trouble viewing this email? View it as a Web page.

NINR - Welcome New Subscriber

January 31, 2019

NINR News & Notes


News & Notes is NINR's online newsletter, providing the latest nursing science discoveries, funding and training opportunities, and news about our events and initiatives.

NINR Events

NINR logo

Announcing the 2019 NINR Director's Lecture Series

NINR invites you to attend the 2019 Director's Lecture Series. The Series is designed to bring the nation's top nurse scientists to the NIH campus to share their work and interests with a transdisciplinary audience.

Read More

photo of Dr. Butz

Dr. Arlene Butz Presents "Understanding Inner-city Pediatric Asthma: Environment Matters"

Dr. Arlene Butz will present "Understanding Inner-city Pediatric Asthma: Environment Matters" on March 7, 2019 from 1:00 p.m. to 2:00 p.m. on the NIH Campus in Bethesda, Maryland.

Read More

NIH Training

scientists in a lab

The Application Period for NINR's Summer Genetics Institute (SGI) is Open!

Applications will be accepted from now until March 1, 2019.

Read More

NIH News

graphic showing thought bubbles

NIH Seeks Information on Behavioral and Social Sciences Research

NIH's Office of Behavioral and Social Sciences Research (OBSSR) has issued a Request for Information (RFI) intended to gather broad public input on a revised definition of behavioral and social sciences research.

Read More


This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud, on behalf of: National Institute of Nursing Research National Institutes of Health · 31 Center Drive, Room 5B10 · Bethesda, MD 20892-2178 GovDelivery logo

Cancer Information Highlights, January 31, 2019

National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
 
New from NCI
Managing Cancer Pain: Are Better Approaches on the Horizon?
Sensory Nerve Fibers in Prostate Tumor Cells   With more people reporting cancer pain and the opioid epidemic affecting how cancer pain is managed, there's renewed interest in developing new pain medicines that are not addictive as well as ways to treat pain that do not involve drugs.
African American Men More Likely to Die from Low-Grade Prostate Cancer
A graphic showing black men have a higher incidence of prostate cancer than white men.   For African American men, the risk of dying from low-grade prostate cancer is double that of men of other races, a new study has found. But, despite the difference, the risk is still small.
Glioblastoma Study Highlights Sex Differences in Brain Cancer

Men and women with glioblastoma appear to respond differently to standard treatment. A new study suggests factors that might help explain this sex difference.

PDQ Summary Updates
Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment

We've revised our PDQ summary on ovarian epithelial cancer with updates to the treatments used for advanced and recurrent disease.
Diagnostic Tests and Staging Descriptions Updated in Several Lymphoma Summaries

We revised our PDQ summaries on adult Hodgkin lymphoma, adult non-Hodgkin lymphoma, and AIDS-related lymphoma. Tests used for diagnosis and the descriptions of the disease stages were updated in each summary.

Drug Information Updates
Cabozantinib-S-Malate Use in Liver Cancer

We've updated our cabozantinib-s-malate drug information summary with a newly approved Food and Drug Administration (FDA) indication. Cabozantinib-s-malate (Cabometyx) is now approved for use in people with hepatocellular carcinoma (a type of liver cancer) who have already been treated with sorafenib.

New Approvals for Leukemia 

We've added a new drug information summary for calaspargase pegol-mknl (Asparlas), which was recently approved by FDA for use in children and young adults with acute lymphoblastic leukemia.

We've added a new drug information summary for gilteritinib fumarate (Xospata), which was recently approved by FDA for use in adults with acute myeloid leukemia that has returned or does not respond to treatment and has a mutation in the FLT3 gene.

 
Also of Interest
Cervical Cancer

When caught early, cervical cancer is very treatable. Learn about cervical cancer risk factors, prevention, early detection, and treatment.
Adjusting to Cancer

Learning that you have cancer can be overwhelming. But learning how to talk about it and knowing what to expect can help you adjust.
Clinical Trials Information for Patients and Families

Clinical trials are crucial in making progress against cancer. Learn about clinical trials, how to find them, and questions to ask the doctor.

 

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892 GovDelivery logo